{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:47:57Z","timestamp":1773949677592,"version":"3.50.1"},"reference-count":22,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3892\/mmr.2014.2263","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T02:09:26Z","timestamp":1400724566000},"page":"1096-1102","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions"],"prefix":"10.3892","volume":"10","author":[{"given":"YONG-BO","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAN","family":"BAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-LING","family":"DU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIAN","family":"XING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YING","family":"BA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUE-YAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUN-HONG","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN-JIE","family":"YAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"key20180108010642_b1-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/dc12-0227","article-title":"Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese","volume":"36","author":"Yang","year":"2013","journal-title":"Diabetes Care"},{"key":"key20180108010642_b2-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108010642_b3-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108010642_b4-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1557-0843(07)80018-2","article-title":"The use of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: advantages and limitations","volume":"2","author":"Rizvi","year":"2007","journal-title":"Insulin"},{"key":"key20180108010642_b5-mmr-10-02-1096","first-page":"896","article-title":"Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial","volume":"32","author":"Miser","year":"2010","journal-title":"Clin The"},{"key":"key20180108010642_b6-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1742-1241.2010.02513.x","article-title":"Improved glycaemic control with reduced hypoglycaemic episodes and without weight gain using long-term modern premixed insulins in type 2 diabetes","volume":"65","author":"Levit","year":"2011","journal-title":"Int J Clin Pract"},{"key":"key20180108010642_b7-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EJE-11-0022","article-title":"Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues","volume":"66","author":"Vaag","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key20180108010642_b8-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1463-1326.2009.01165.x","article-title":"Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study","volume":"12","author":"Fritsche","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"key20180108010642_b9-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/dc10-1710","article-title":"Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials","volume":"34","author":"Giugliano","year":"2011","journal-title":"Diabetes Care"},{"key":"key20180108010642_b10-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1742-1241.2007.01598.x","article-title":"Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice","volume":"61","author":"Hammer","year":"2007","journal-title":"Int J Clin Pract"},{"key":"key20180108010642_b11-mmr-10-02-1096","first-page":"3115","article-title":"Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen","volume":"87","author":"Bu","year":"2007","journal-title":"Zhong Hua Yi Xue Za Zhi"},{"key":"key20180108010642_b12-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1463-1326.2008.00873.x","article-title":"Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial","volume":"10","author":"Davies","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"key20180108010642_b13-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1742-1241.2012.03000.x","article-title":"Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study","volume":"66","author":"G\u00f3mez-Peralta","year":"2012","journal-title":"Int J Clin Pract"},{"key":"key20180108010642_b14-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1185\/03007995.2012.671764","article-title":"A prospective study to optimize insulin treatment by switching to insulin glargine in type 2 diabetic patients previously uncontrolled on premixed insulin: the optimization study","volume":"28","author":"Yang","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"key20180108010642_b15-mmr-10-02-1096","first-page":"419","article-title":"Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function","volume":"29","author":"Li","year":"2004","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"key20180108010642_b16-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4158\/EP10079.OR","article-title":"A comparison of twice-daily biphasic insulin aspart 70\/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study","volume":"17","author":"Ligthelm","year":"2011","journal-title":"Endocr Pract"},{"key":"key20180108010642_b17-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/diacare.28.2.419","article-title":"Good glycemic control with flexibility in timing of basal insulin supply: a 24-week com-parison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride","volume":"28","author":"Standl","year":"2005","journal-title":"Diabetes Care"},{"key":"key20180108010642_b18-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.28.2.254","article-title":"Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes","volume":"28","author":"Janka","year":"2005","journal-title":"Diabetes Care"},{"key":"key20180108010642_b19-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.2337\/dc11-1064","article-title":"Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus","volume":"34","author":"Porcellati","year":"2011","journal-title":"Diabetes Care"},{"key":"key20180108010642_b20-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"key20180108010642_b21-mmr-10-02-1096","first-page":"125","article-title":"Style and quality of life in patients with type 2 diabetes","volume":"49","author":"Romero-M\u00e1rquez","year":"2011","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"key20180108010642_b22-mmr-10-02-1096","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5539\/gjhs.v4n6p185","article-title":"A review about the effect of life style modification on diabetes and quality of life","volume":"4","author":"Shrestha","year":"2012","journal-title":"Glob J Health Sci"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2263\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:26:52Z","timestamp":1515360412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,5,22]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3892\/mmr.2014.2263"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2263","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}